Compass Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Compass Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2019 to Q2 2024.
  • Compass Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.12M, a 30.3% increase year-over-year.
  • Compass Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $7.35M, a 41.1% increase year-over-year.
  • Compass Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $6.12M, a 14.8% increase from 2022.
  • Compass Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.33M, a 32.3% increase from 2021.
  • Compass Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.03M, a 0.32% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $7.35M $2.12M +$493K +30.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $6.86M $2M +$736K +58.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $6.12M $1.6M +$575K +56.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $5.55M $1.63M +$338K +26.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $5.21M $1.63M +$184K +12.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $5.02M $1.27M -$307K -19.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $5.33M $1.03M -$121K -10.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $5.45M $1.29M +$300K +30.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $5.15M $1.44M +$496K +52.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $4.66M $1.57M +$626K +66% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $4.03M $1.15M +$96K +9.14% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $3.93M $987K -$1.55M -61.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $5.48M $948K +$765K +418% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-01
Q1 2021 $4.72M $948K +$701K +284% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $4.02M $1.05M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-18
Q3 2020 $2.54M +$2.29M +918% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $183K -$2K -1.08% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $247K Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q3 2019 $249K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $185K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.